10-07-2024, 05:19 AM
Armotraz, which contains anastrozole, is an effective treatment for breast cancer, especially in postmenopausal women. It belongs to the class of medications known as aromatase inhibitors. Armotraz works by blocking the aromatase enzyme, which converts androgens (male hormones) to estrogen in the body. This conversion process accounts for the majority of circulating estrogen in postmenopausal women. Because many breast cancers are fuelled by estrogen, lowering its levels can dramatically reduce or stop the growth of these cancer cells. By reducing estrogen levels, Armotraz effectively starves hormone-sensitive cancers, preventing them from developing and spreading. This is especially advantageous for individuals with estrogen receptor-positive (ER-positive) breast cancer, in which cancer cells rely on estrogen for proliferation. Armotraz is usually taken as a pill once a day, with or without food. Depending on individual circumstances and therapeutic responses, treatment can last several years. To summarize, Armotraz inhibits the growth of certain forms of breast cancer by blocking estrogen synthesis in postmenopausal women. Regular monitoring and interactions with healthcare providers are required to guarantee treatment efficacy and control potential side effects.
Have all details: Generic cures
Have all details: Generic cures